Pure Global
Turkey ÜTS registration 339787c015e9efcc42575cf83d8db7ff

DARZALEX 1800 MG SC SOLUTION FOR INJECTION, 1 PIECE

TR: DARZALEX 1800 MG SC ENJEKSİYONLUK ÇÖZELTİ, 1 ADET
Turkey flagTurkey·Pharmaceutical Product·JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ.·Licensed Dec 26, 2022
License details
Product ID (UID)
339787c015e9efcc42575cf83d8db7ff
License Number
2022/798
Barcode
8699593775154
ATC Code
L01FC01
License holder information
License Holder
JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ.
Active ingredient & license information
Active Ingredient (EN)
Daratumumab
License Date
Dec 26, 2022
About this record

Access comprehensive regulatory information for DARZALEX 1800 MG SC SOLUTION FOR INJECTION, 1 PIECE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 339787c015e9efcc42575cf83d8db7ff with license number 2022/798and contains active ingredient Daratumumab . The license is held by JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI21,000+ Products